Skip to main content

Ashley Xu

Analyst

Piper Sandler

Equibles does not estimate personal net worth.

About Ashley Xu

Ashley Xu is recorded as Analyst at Piper Sandler. Ashley Xu has spoken on 3 earnings calls and 1 other investor event across 4 companies, most recently for Rigel Pharmaceuticals Inc on May 12, 2026. Those appearances were for Rigel Pharmaceuticals Inc (RIGL), Alx Oncology Holdings Inc (ALXO), Ardelyx, Inc. (ARDX) and Akebia Therapeutics, Inc. (AKBA). The companies whose calls Ashley Xu spoke on are classified in the Healthcare sector.

Ashley Xu on recent calls

“I was just curious to get your thoughts and also hear Dr. Hamilton chime in. With the label requiring an FDA-authorized test for ESR1 You know, what's the strategy for ensuring broad access, you know, to diagnostic testing, you know, to facilitate rapid patient identification and uptake?”
Analyst — Piper Sandler, Rigel Pharmaceuticals, Inc. VEPPANU (vepdegestrant) Licensing Agreement Conference Call ·
“So just curious to learn what's the latest on the companion diagnostic development. I know you guys have talked about this on previous earnings calls. So just looking for some updated thoughts there.”
Analyst — Piper Sandler, Alx Oncology Holdings Inc Q1 FY2026 Earnings Call ·
“You talked about it in your prepared remarks, but could you talk a little more about the Absarilla pediatric trials and just the workings of the potential six months of additional patent life and how meaningful those additional six months could be for Absarilla?”
Analyst — Piper Sandler, Ardelyx, Inc. Q1 FY2026 Earnings Call ·
“Just one question from us, because you guys did a great job of answering our other questions, but just on the R&D day on April 2nd, when you're discussing your pipeline, can you help frame some expectations for investors?”
Analyst — Piper Sandler, Akebia Therapeutics, Inc. Q4 FY2025 Earnings Call ·

Affiliation history

  • Piper Sandler

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity